Cape Investment Advisory’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-350
| Closed | -$1.06K | – | 1203 |
|
|
2024
Q4 | $1.06K | Hold |
350
| – | – | ﹤0.01% | 955 |
|
|
2024
Q3 | $1.82K | Sell |
350
-97
| -22% | -$504 | ﹤0.01% | 835 |
|
|
2024
Q2 | $1.15K | Hold |
447
| – | – | ﹤0.01% | 828 |
|
|
2024
Q1 | $2.2K | Hold |
447
| – | – | ﹤0.01% | 755 |
|
|
2023
Q4 | $3.93K | Hold |
447
| – | – | ﹤0.01% | 816 |
|
|
2023
Q3 | $5.13K | Sell |
447
-430
| -49% | -$4.93K | ﹤0.01% | 668 |
|
|
2023
Q2 | $22.2K | Hold |
877
| – | – | 0.01% | 421 |
|
|
2023
Q1 | $28.2K | Buy |
+877
| New | +$28.2K | 0.02% | 367 |
|